Results 161 to 170 of about 359,969 (268)

Cost-Effectiveness of Contemporary Surgical Treatment Options for Benign Prostatic Hyperplasia. [PDF]

Urology
Wymer KM, Lehner K, Sharma V, Ratcliff G, Botkin H, Borah B, Kelleher D, Forbes CM, Humphreys M, Joyce DD.   +9 more
europepmc   +1 more source

Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability

, 2014
Hee Ju Cho, Tag Keun Yoo Department of Urology, Eulji Hospital, Eulji University School of Medicine, Seoul, KoreaAbstract: α1-Adrenergic receptor antagonists are commonly used to treat male lower urinary tract symptoms and benign prostatic ...
Yoo TK, Cho HJ
core  

Improvement of Erectile Function After Switching From Valsartan to Olmesartan Within a Fixed‐Dose Antihypertensive Combination: A Case Report

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Intra‐class differences may exist between ARBs regarding tissue‐specific outcomes. In this case, valsartan was probably associated with erectile dysfunction (Naranjo score 7). Switching to olmesartan was followed by resolutions of symptoms. An intra‐class switch may be considered in selected patients with suspected drug‐associated erectile ...
Mario Ćurković, Nika Ćurković
wiley   +1 more source

Reframing Benign Prostatic Hyperplasia as a Cardiometabolic Condition: Should BPH Be Considered a Metabolic Disease? [PDF]

Rev Cardiovasc Med
Dimitriadou I, Samarinas M.
europepmc   +1 more source

Gestational Low Protein Diet Increases the Susceptibility to N‐Bis(2‐Hydroxypropyl)nitrosamine‐Induced Lung Tumors in Female Wistar Rats

Environmental and Molecular Mutagenesis, Volume 67, Issue 8-9, October-November 2026.
ABSTRACT This study evaluated the susceptibility to lung and kidney carcinogenesis induced by N‐bis(2‐hydroxypropyl)nitrosamine (DHPN) in female rats whose dams received a low‐protein diet (LPD) during gestation. Pregnant Wistar rats were fed normal protein diet (NPD, 17% protein) or LPD (6% protein).
Vanessa de Cássia Martins Pires Ferreira, Victor Hugo Carvalho, Patrícia Aline Boer, Luís Fernando Barbisan   +3 more
wiley   +1 more source

Assessment of Potential Drug‐Drug Interactions in Hospitalized Patients With Cardiovascular Diseases at Kenyatta National Hospital, Nairobi, Kenya: A Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background and Aim Drug–drug interactions (DDIs) occur when the pharmacological effect of one medication is altered by the concurrent administration of another, potentially leading to reduced therapeutic efficacy or increased risk of adverse effects.
Brenda Koech, Ermias Terefe
wiley   +1 more source

Comparative Analysis of Alcohol and Aldehyde Dehydrogenase Activities in Prostate Cancer and Benign Prostatic Hyperplasia. [PDF]

J Clin Med
Nowiński AR, Jelski W, Skrodzka M, Mroczko B, Gryko M, Orywal K.   +5 more
europepmc   +1 more source

Identification of angiogenesis-related genes in the diagnosis of benign prostatic hyperplasia using bioinformatics analysis. [PDF]

Transl Androl Urol
Cui M, Kostadinovic K, Meng Q, Bai T, Gu Y, Liu S.   +5 more
europepmc   +1 more source

Technical Feasibility of IVIM for Prostate Cancer Imaging Using High‐Amplitude Whole‐Body Gradient System With Spiral Readout and Velocity‐Compensated Diffusion Encoding

NMR in Biomedicine, Volume 39, Issue 10, October 2026.
The combination of velocity‐compensated diffusion encoding, spiral readout and strong gradients enabled high‐quality prostate IVIM imaging, offering a promising framework for the development of reliable IVIM‐based biomarkers for prostate cancer detection, characterisation and monitoring.
Malwina Molendowska, Ivan A. Rashid, Kieran Foley, Lars Mueller, Lars E. Olsson, Patrik Brynolfsson, Filip Szczepankiewicz   +6 more
wiley   +1 more source

<i>Lycopus lucidus</i> Extract Attenuates Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats. [PDF]

Pharmaceuticals (Basel)
An S, Park CH, Gao E, Song J.
europepmc   +1 more source